investorscraft@gmail.com

Intrinsic ValueIperionX Limited (IPX)

Previous Close$49.93
Intrinsic Value
Upside potential
Previous Close
$49.93

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2025 and quarterly data as of .

Data is not available at this time.

Stock Valuation Context

Business Model And Market Position

IperionX Limited operates in the advanced materials and sustainable manufacturing sector, focusing on the production of titanium and other critical minerals using innovative, low-carbon technologies. The company’s core revenue model is centered around licensing its proprietary titanium production processes, selling titanium products, and developing recycling solutions for titanium scrap. Positioned as a disruptor in the metals industry, IperionX aims to capitalize on the growing demand for sustainable and domestically sourced critical materials, particularly in aerospace, defense, and medical applications. The company’s patented Hydrogen Assisted Metallothermic Reduction (HAMR) technology differentiates it from traditional titanium producers by offering a cost-effective and environmentally friendly alternative. With strategic partnerships and government support, IperionX is positioning itself as a key player in the reshoring of critical mineral supply chains, addressing both geopolitical and environmental concerns in the market.

Revenue Profitability And Efficiency

IperionX reported no revenue for the fiscal year ending June 2024, reflecting its pre-commercial stage. The company posted a net loss of $22.2 million, with an operating cash flow deficit of $18.6 million, indicating significant investment in R&D and operational scaling. Capital expenditures totaled $8.1 million, underscoring its focus on infrastructure and technology development to support future production capabilities.

Earnings Power And Capital Efficiency

The company’s diluted EPS of -$1.00 highlights its current lack of earnings power as it invests heavily in growth initiatives. With no revenue streams yet operational, capital efficiency metrics remain negative, though the $33.2 million in cash reserves provides a runway to advance its technology and commercialization efforts.

Balance Sheet And Financial Health

IperionX maintains a solid liquidity position with $33.2 million in cash and equivalents, against minimal total debt of $1.5 million. This strong balance sheet supports its ability to fund ongoing operations and strategic investments without immediate financial strain, though continued losses may necessitate additional capital raises in the future.

Growth Trends And Dividend Policy

As a development-stage company, IperionX does not pay dividends, reinvesting all resources into growth. The focus remains on scaling its titanium production technology and securing commercial partnerships. The absence of revenue trends makes growth assessment speculative, but the company’s progress in pilot projects and government grants suggests potential for future revenue streams.

Valuation And Market Expectations

Market expectations for IperionX are tied to its ability to commercialize its technology and secure long-term contracts. The lack of revenue and profitability metrics makes traditional valuation challenging, but investor sentiment appears optimistic given its strategic positioning in sustainable critical minerals and potential for industry disruption.

Strategic Advantages And Outlook

IperionX’s key advantages include its proprietary low-carbon titanium production technology and strong government and industry partnerships. The outlook hinges on successful commercialization and scaling, with potential upside from increasing demand for sustainable materials. However, execution risks and competition from established players remain critical challenges to monitor.

Sources

Company filings, investor presentations

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2026202720282029203020312032203320342035203620372038203920402041204220432044204520462047204820492050

INCOME STATEMENT

Revenue growth rate, %NaN
Revenue, $NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $mNaN
Operating income, $mNaN
EBITDA, $mNaN
Interest expense (income), $mNaN
Earnings before tax, $mNaN
Tax expense, $mNaN
Net income, $mNaN

BALANCE SHEET

Cash and short-term investments, $mNaN
Total assets, $mNaN
Adjusted assets (=assets-cash), $mNaN
Average production assets, $mNaN
Working capital, $mNaN
Total debt, $mNaN
Total liabilities, $mNaN
Total equity, $mNaN
Debt-to-equity ratioNaN
Adjusted equity ratioNaN

CASH FLOW

Net income, $mNaN
Depreciation, amort., depletion, $mNaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $mNaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $mNaN
Free cash flow, $mNaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $mNaN
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount